Fresh Recalls

Baxter Healthcare recalls

34 recent recalls on record for Baxter Healthcare in connected official government data as of October 22, 2026 at 6:00 PM UTC.

Models with recalls

0 (1)Adapter for Head Positioning (1)Baxter Duo-Vent Solution Set and Male Luer Lock Adapter (1)Baxter Novum IQ Syringe Pump (2)Brand Name (2)CARDENE IV (Nicardipine Hydrochloride) in 0 (1)Cefazolin in Dextrose (2)Clindamycin Injection USP in 5% Dextrose (4)Clindamycin Phosphate in 0 (1)Daptomycin (2)Dexmedetomidine Hydrochloride in 0 (1)Dextrose Injection (1)Famotidine Injection in Sodium Chloride Injection (1)Hillrom VOLARA P (1)Hillrom VOLARA System P (3)MYXREDLIN (1)Nexterone (amiodarone HCI) (1)PRO+ 36" MRS SURFACE (1)PRO+ 40" MRS SURFACE (1)PRO+ MRS SURFACE FOR VERSACARE (1)Pantoprazole Sodium in 0 (1)Vancomycin Injection (2)Vasopressin (2)

All Baxter Healthcare recalls

FDA Class II · Medical device · September 30, 2026

PRO+ 40" MRS SURFACE recall — Baxter Healthcare Corporation

There is an error in the product description on the Unique Device Identification (UDI) label. These discrepancies in labeling do not align with the approved product or product spec…

Official ID Z-3264-2026 · Official record ↗

FDA Class II · Medical device · September 30, 2026

PRO+ 36" MRS SURFACE recall — Baxter Healthcare Corporation

There is an error in the product description on the Unique Device Identification (UDI) label. These discrepancies in labeling do not align with the approved product or product spec…

Official ID Z-3263-2026 · Official record ↗

FDA Class II · Medical device · September 30, 2026

PRO+ MRS SURFACE FOR VERSACARE recall — Baxter Healthcare Corporation

There is an error in the product description on the Unique Device Identification (UDI) label. These discrepancies in labeling do not align with the approved product or product spec…

Official ID Z-3262-2026 · Official record ↗

FDA Class II · Medical device · September 30, 2026

Brand Name recall — Baxter Healthcare Corporation

Contamination within the release test equipment flow path could have affected the accuracy of the nebulizer flow rate. Affected devices returned to firm and testing confirmed devic…

Official ID Z-3257-2026 · Official record ↗

FDA Class I · Drug · September 16, 2026

Dextrose Injection recall — Baxter Healthcare Corporation

Presence of Particulate Matter: particulate matter identified as stainless steel particles in the solution.

Official ID D-0850-2026 · Official record ↗

FDA Class II · Medical device · September 9, 2026

Baxter Novum IQ Syringe Pump recall — Baxter Healthcare Corporation

A software issue that may occur during a Volume/Time (VOT) multi-syringe infusion when a syringe reaches empty and is replaced while a Volume To Be Infused (VTBI) remains.

Official ID Z-3066-2026 · Official record ↗

FDA Class II · Medical device · September 9, 2026

Baxter Novum IQ Syringe Pump recall — Baxter Healthcare Corporation

A software issue that may occur during a Volume/Time (VOT) multi-syringe infusion when a syringe reaches empty and is replaced while a Volume To Be Infused (VTBI) remains.

Official ID Z-3065-2026 · Official record ↗

FDA Class I · Drug · September 9, 2026

0 recall — Baxter Healthcare Corporation

Presence of particulate matter: Particulates identified as fiberglass

Official ID D-0849-2026 · Official record ↗

FDA Class II · Drug · September 9, 2026

Daptomycin recall — Baxter Healthcare Corporation

CGMP Deviations

Official ID D-0821-2026 · Official record ↗

FDA Class II · Drug · September 9, 2026

Vancomycin Injection recall — Baxter Healthcare Corporation

CGMP Deviations

Official ID D-0820-2026 · Official record ↗

FDA Class II · Drug · September 9, 2026

Vasopressin recall — Baxter Healthcare Corporation

CGMP Deviations

Official ID D-0819-2026 · Official record ↗

FDA Class II · Drug · September 9, 2026

Clindamycin Injection USP in 5% Dextrose recall — Baxter Healthcare Corporation

CGMP Deviations

Official ID D-0818-2026 · Official record ↗

FDA Class II · Drug · September 9, 2026

Clindamycin Injection USP in 5% Dextrose recall — Baxter Healthcare Corporation

CGMP Deviations

Official ID D-0817-2026 · Official record ↗

FDA Class II · Drug · September 9, 2026

Clindamycin Phosphate in 0 recall — Baxter Healthcare Corporation

CGMP Deviations

Official ID D-0816-2026 · Official record ↗

FDA Class II · Drug · September 9, 2026

Clindamycin Injection USP in 5% Dextrose recall — Baxter Healthcare Corporation

CGMP Deviations

Official ID D-0815-2026 · Official record ↗

FDA Class II · Drug · September 9, 2026

Nexterone (amiodarone HCI) recall — Baxter Healthcare Corporation

CGMP Deviations

Official ID D-0814-2026 · Official record ↗

FDA Class II · Drug · September 9, 2026

CARDENE IV (Nicardipine Hydrochloride) in 0 recall — Baxter Healthcare Corporation

CGMP Deviations

Official ID D-0813-2026 · Official record ↗

FDA Class II · Drug · September 9, 2026

Pantoprazole Sodium in 0 recall — Baxter Healthcare Corporation

CGMP Deviations

Official ID D-0812-2026 · Official record ↗

FDA Class II · Drug · September 9, 2026

Vasopressin recall — Baxter Healthcare Corporation

CGMP Deviations

Official ID D-0811-2026 · Official record ↗

FDA Class II · Drug · September 9, 2026

Dexmedetomidine Hydrochloride in 0 recall — Baxter Healthcare Corporation

CGMP Deviations

Official ID D-0810-2026 · Official record ↗

FDA Class II · Drug · September 9, 2026

Famotidine Injection in Sodium Chloride Injection recall — Baxter Healthcare Corporation

CGMP Deviations

Official ID D-0809-2026 · Official record ↗

FDA Class II · Drug · September 9, 2026

Clindamycin Injection USP in 5% Dextrose recall — Baxter Healthcare Corporation

CGMP Deviations

Official ID D-0808-2026 · Official record ↗

FDA Class II · Drug · September 9, 2026

Daptomycin recall — Baxter Healthcare Corporation

CGMP Deviations

Official ID D-0807-2026 · Official record ↗

FDA Class II · Drug · September 9, 2026

MYXREDLIN recall — Baxter Healthcare Corporation

CGMP Deviations

Official ID D-0806-2026 · Official record ↗

FDA Class II · Drug · September 9, 2026

Vancomycin Injection recall — Baxter Healthcare Corporation

CGMP Deviations

Official ID D-0805-2026 · Official record ↗

FDA Not Yet Classified · Drug · August 19, 2026

Cefazolin in Dextrose recall — Baxter Healthcare Corporation

Presence of Particulate Matter

Official ID EVT-99463-1krekt6 · Official record ↗

FDA Class I · Medical device · August 19, 2026

Baxter Duo-Vent Solution Set and Male Luer Lock Adapter recall — Baxter Healthcare Corporation

Baxter received customer reports of air bubbles in the drip chamber and tubing when a pressure cuff is in use or when the tubing is flushed at the fully open position.

Official ID Z-2766-2026 · Official record ↗

FDA Class I · Drug · August 19, 2026

Cefazolin in Dextrose recall — Baxter Healthcare Corporation

Presence of Particulate Matter

Official ID D-0787-2026 · Official record ↗

FDA Class II · Medical device · July 8, 2026

Adapter for Head Positioning recall — Baxter Healthcare Corporation

The Adapter for Head Positioning accessory may become loose during patient positioning and unintentionally move when used in conjunction with the side rails of the Upper Back Secti…

Official ID Z-2638-2026 · Official record ↗

FDA Class I · Medical device · July 8, 2026

Hillrom VOLARA System P recall — Baxter Healthcare Corporation

There have been reports of air and medication leakage from the nebulizer cup during therapy of Volara system patient circuits. The leakage can lead to an oxygen level drop in the p…

Official ID Z-2551-2026 · Official record ↗

FDA Class I · Medical device · July 8, 2026

Hillrom VOLARA System P recall — Baxter Healthcare Corporation

There have been reports of air and medication leakage from the nebulizer cup during therapy of Volara system patient circuits. The leakage can lead to an oxygen level drop in the p…

Official ID Z-2550-2026 · Official record ↗

FDA Class I · Medical device · July 8, 2026

Hillrom VOLARA P recall — Baxter Healthcare Corporation

There have been reports of air and medication leakage from the nebulizer cup during therapy of Volara system patient circuits. The leakage can lead to an oxygen level drop in the p…

Official ID Z-2549-2026 · Official record ↗

FDA Class I · Medical device · July 8, 2026

Hillrom VOLARA System P recall — Baxter Healthcare Corporation

There have been reports of air and medication leakage from the nebulizer cup during therapy of Volara system patient circuits. The leakage can lead to an oxygen level drop in the p…

Official ID Z-2548-2026 · Official record ↗

FDA Class II · Medical device · June 10, 2026

Brand Name recall — Baxter Healthcare Corporation

Affected lots may contain incorrect 0.8-micron filters. Use of a 0.8-micron filter in place of the validated 3-micron filter may lead to reduced flow efficiency, incomplete or slow…

Official ID Z-2262-2026 · Official record ↗

Verify with the official sources:

Found something wrong or missing? Report a data error.

Compiled from official public-domain government data. Last checked October 22, 2026 at 6:00 PM UTC.